GlassScriptPhysician profile
Allen B Kantrowitz
NPI 1841258464
$3,439.23
in general payments reported to CMS, 2019-2025
23 companies · $490 in 2025
The $490 reported for 2025 was less than what a typical Neurological Surgery provider received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $218 · 2020: $282 · 2021: $421 · 2022: $1,467 · 2023: $240 · 2024: $323 · 2025: $490.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,052.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,051.75 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Integrity Implants INC. | $613.72 | 2022 | |
| Stryker Corporation | $573.42 | 2019-2025 | Everest Spinal System |
| Medtronic, INC. | $407.62 | 2021-2024 | Midas Rex, Magnifuse Bone Graft, N/A |
| Penumbra, INC. | $336.49 | 2022 | |
| Carlsmed, INC. | $302.68 | 2022-2023 | Aprevo |
| Aesculap, INC. | $250.00 | 2025 | Xabo |
| Medtronic USA, INC. | $162.15 | 2019-2020 | |
| Depuy Synthes Sales INC. | $113.41 | 2020-2023 | Teligen |
| Globus Medical, INC. | $107.21 | 2023-2025 | Adira, Alif Instruments (Universal) |
| Kci USA, INC. | $98.18 | 2022 | |
| Alexion Pharmaceuticals, INC. | $76.76 | 2022 | |
| Integra Lifesciences Corporation | $64.49 | 2019-2025 | Codman Isocool Aht, Integra Duo, Microfrance |
| Bioventus LLC | $44.26 | 2025 | Bonescalpel & Sonicone (O.R.) |
| Astrazeneca Pharmaceuticals LP | $43.29 | 2021-2022 | |
| Livanova USA, INC. | $43.16 | 2020 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nuvasive, INC. | $41.30 | 2019-2020 | |
| Orthofix Medical, INC. | $30.97 | 2025 | Cervical-Stim |
| Zimvie INC. | $25.16 | 2023 | |
| Chiesi USA, INC. | $25.09 | 2022 | |
| Si-Bone, INC. | $24.23 | 2022 | |
| Omniscient Neurotechnology America LTD | $23.32 | 2023 | Quicktome |
| Arteriocyte Medical Systems, INC. | $19.00 | 2022 | |
| Theragen, INC. | $13.32 | 2024 | Actastim-S |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Allen Kantrowitz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.